SANDRI, Gilda
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.884
NA - Nord America 8.487
AS - Asia 5.831
SA - Sud America 839
AF - Africa 176
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 6
Totale 33.274
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.715
US - Stati Uniti d'America 8.242
SG - Singapore 1.748
CN - Cina 1.636
GB - Regno Unito 1.330
HK - Hong Kong 652
BR - Brasile 627
VN - Vietnam 617
NL - Olanda 512
DE - Germania 391
SE - Svezia 364
FR - Francia 332
FI - Finlandia 270
KR - Corea 237
RU - Federazione Russa 209
TR - Turchia 185
UA - Ucraina 180
IN - India 139
ID - Indonesia 126
CA - Canada 123
AR - Argentina 84
CH - Svizzera 82
ES - Italia 80
JP - Giappone 79
MX - Messico 77
BD - Bangladesh 71
BG - Bulgaria 62
IE - Irlanda 60
PL - Polonia 56
IQ - Iraq 52
ZA - Sudafrica 50
AU - Australia 44
AT - Austria 43
PK - Pakistan 37
MA - Marocco 34
BE - Belgio 33
CO - Colombia 29
MY - Malesia 27
PH - Filippine 26
AE - Emirati Arabi Uniti 23
EG - Egitto 23
NO - Norvegia 23
TW - Taiwan 22
CZ - Repubblica Ceca 21
IR - Iran 21
EC - Ecuador 20
PE - Perù 19
SA - Arabia Saudita 19
VE - Venezuela 19
CL - Cile 18
RO - Romania 17
KE - Kenya 15
GR - Grecia 14
LT - Lituania 14
AL - Albania 13
MT - Malta 13
NP - Nepal 11
PY - Paraguay 11
IL - Israele 10
KZ - Kazakistan 10
TH - Thailandia 10
UZ - Uzbekistan 10
BH - Bahrain 9
BO - Bolivia 9
PT - Portogallo 9
TN - Tunisia 9
DZ - Algeria 8
AZ - Azerbaigian 7
BZ - Belize 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
NZ - Nuova Zelanda 7
HU - Ungheria 6
LV - Lettonia 6
OM - Oman 6
BY - Bielorussia 5
GT - Guatemala 5
JO - Giordania 5
KG - Kirghizistan 5
MK - Macedonia 5
PA - Panama 5
SN - Senegal 5
CR - Costa Rica 4
HN - Honduras 4
NG - Nigeria 4
NI - Nicaragua 4
SY - Repubblica araba siriana 4
AM - Armenia 3
CI - Costa d'Avorio 3
GE - Georgia 3
KH - Cambogia 3
LB - Libano 3
MD - Moldavia 3
QA - Qatar 3
RS - Serbia 3
SI - Slovenia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CG - Congo 2
DK - Danimarca 2
Totale 33.224
Salva come PNG Salva come JPEG
Città #
Rome 1.218
Santa Clara 1.199
Singapore 1.105
Milan 1.104
Southend 872
Ashburn 841
Hefei 655
Hong Kong 640
San Jose 539
Naples 445
Fairfield 428
Chandler 408
Bologna 343
Florence 318
Turin 283
Woodbridge 258
Jacksonville 253
London 248
Houston 246
Seoul 224
Beijing 214
Bari 208
Ho Chi Minh City 206
Los Angeles 205
Nyköping 199
Dearborn 196
Helsinki 189
Ann Arbor 180
Wilmington 171
Chicago 162
Modena 159
The Dalles 156
Seattle 153
Catania 145
Parma 144
Genoa 138
Council Bluffs 137
Hanoi 137
Palermo 132
New York 121
Cambridge 111
Verona 106
Izmir 92
Jakarta 92
Brescia 91
Lauterbourg 89
São Paulo 84
Moscow 83
Padova 83
Cagliari 76
Pescara 72
Munich 71
Reggio Emilia 70
Shanghai 69
Princeton 64
Buffalo 62
Orem 60
San Diego 60
Salt Lake City 59
Trieste 58
Livorno 57
Sofia 57
Tokyo 55
Dallas 52
Vicenza 52
Trento 50
Rimini 47
Frankfurt am Main 46
Eugene 44
Mexico City 41
Perugia 39
Tampa 38
Ancona 35
Bremen 35
Des Moines 35
Elk Grove Village 35
Toronto 35
Da Nang 34
Kent 34
Venice 34
Dublin 32
Redwood City 32
Amsterdam 31
Boardman 31
Monza 30
Ottawa 30
Paris 30
Treviso 30
Salerno 29
Taranto 29
Bergamo 28
Falkenstein 28
Messina 28
Ovada 28
Warsaw 28
Stockholm 27
Valencia 27
Cesena 25
Chennai 25
Columbus 24
Totale 17.958
Salva come PNG Salva come JPEG
Nome #
Farmaci biologici e rischio oncologico 4.496
Tempi di sospensione dei farmaci biologici nello switch terapeutico e nella programmazione degli interventi chirurgici 4.433
L’infezione da papilloma virus umano (HPV) nei pazienti con artrite reumatoide trattati con farmaci biologici 3.757
Farmaci biologici e infezione tubercolare 544
Evoluzione dello CSURI (Capillaroscopic Skin Ulcer Risk Index) in pazienti affetti da sclerosi sistemica in terapia con antiendotelina-1 e prostanoidi 445
Diagnostic accuracy of a velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: The InSPIRAtE validation study (INterStitial pneumonia in rheumatoid ArThritis with an electronic device) 398
Farmaci biologici e tematiche relative alla cardiopatia ischemica e all’insufficienza cardiaca 357
Biological Therapy and Risk of Malignancies: A Literature Review 353
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 330
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 326
Frequency and Results of Cryoglobulin Retesting in 4,963 Patients: Comment on the Article by Kolopp-Sarda et al 315
Cryoglobulin evaluation: analysis of intra-laboratory and inter-laboratory variability 310
Non HCV-related mixed cryoglobulinemia 309
The discrepancy between clinical and ultrasonographic remission in rheumatoid arthritis is not related to therapy or autoantibody status. 308
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 303
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 294
La legislazione del dolore e la sua applicazione in Italia: pregi e difetti 284
Early Occupational Therapy Intervention: Patients’ Occupational Needs 276
Beyond cat scratch disease: a case report of bartonella infection mimicking vasculitic disorder 267
EULAR guidelines on ANCA-associated vasculitis in the real life 265
ANTI - TUMOR NECROSIS FACTOR ALPHA (ANTI-TNF) DRUGS IN RHEUMATOID ARTHRITIS: COMPARISON ON DISEASE MANAGEMENT BEFORE AND AFTER THE INTRODUCTION OF THESE BIOLOGICAL DRUGS IN MODENA, ITALY 262
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA): THE RELATIONSHIP BETWEEN SEX, AGE AND ANTIGENIC SPECIFICITIES 261
Ultrasonography in the diagnosis and management of patients with inflammatory arthritides 253
COMPLEMENT DEPLETION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB: A MARKER OF CLINICAL EFFICACY? 245
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 244
EXPERIMENTAL USE OF 3D PRINTING TECHNOLOGY FOR THE CONSTRUCTION OF DEVICES AS INTEGRATION OF OCCUPATIONAL THERAPY INTERVENTION WITH RHEUMATOID ARTHRITIS PATIENTS (RA) 240
Epstein-barr virus reactivation after infliximab in rheumatoid arthritis: a case report. 239
The prevalence of asymptomatic early sacroiliitis in Crohn’s disease patients: The single experience of an Italian tertiary care centre 239
Salivary 1H-NMR Metabolomics in Primary Sjögren Syndrome. Preliminary Results of a Pilot Case-Control Study 238
Le crioglobuline miste: epidemiologia, clinica ed eziopatogenesi. Contributo personale. 236
Non-Hodgkin Lymphoma in Psoriatic Arthritis Treated with Sequential, Multiple Anti-TNF-α Agents: A Case Report 236
Immunodeficiency and autoimmune phenomena in female hyper-IgM syndrome 235
RETENTION RATE OF ADALIMUMAB AND ABP 501 IN THE TREATMENT OF A LARGE COHORT OF PATIENTS WITH INFLAMMATORY ARTHRITIS: A REAL LIFE RETROSPECTIVE ANALYSIS 235
L’uso dei farmaci biologici durante la gravidanza e l’allattamento 233
HCV associated cryoglobulinemic vasculitis 233
Adalimumab and ABP 501 in the Treatment of a Large Cohort of Patients with Inflammatory Arthritis: A Real Life Retrospective Analysis 233
Sanitary costs of osteoarthritis 229
Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients 228
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 228
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 223
Metabolic Profile of Whole Unstimulated Saliva in Patients with Sjögren's Syndrome 220
PREVALENCE OF ULTRASOUND ABNORMALITIES IN PATIENTS WITH PSORIATIC ARTHRITIS IN A CLINICAL PHASE OF MINIMAL DISEASE ACTIVITY UNDER ANTI-TNF TREATMENT 213
NATURAL HISTORY OF CRYOGLOBULINEMIA FROM 2000 TO 2018 FROM THE LABORATORY POINT OF VIEW: AN ANALYSIS OF CRYOGLOBULIN CHARACTERISTICS IN A SINGLE CENTER. 212
Indicazioni chirurgiche alla artrodesi totale di polso nei pazienti affetti da artrite reumatoide. 211
On- and off-label use of rituximab in rheumatic diseases 205
Farmaci biologici ed epatiti da virus B e C 203
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 203
EXPERIENCE OF MULTIDISCIPLINARY TEAM FOR COMPLEX HAND FUNCTION PROBLEMS AT THE RHEUMATOLOGY OUTPATIENT CLINIC OF MODENA 202
Risankizumab e Upadacitinib nel Trattamento dell'Artrite Psoriasica: Meccanismi Diversi, Obiettivo Comune 201
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 200
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study (2023-02-07) 196
UTILITY OF A SELF ADMINISTERED QUESTIONNAIRE AS A TOOL FOR SCREENING JOINT INVOLVEMENT UNDERWAY PSORIASIS 191
Baseline Ultrasound Assessment Improves the Response to Apremilast in Patients with Psoriatic Arthritis: Results from a Multicentre Study 189
Efficacia e sicurezza delle vaccinazioni anti-influenza e anti-pneumococco nei pazienti con artrite reumatoide trattati con farmaci biologici 189
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 189
Apremilast retention rate in clinical practice: observations from an Italian multi-center study 188
ORAL MANIFESTATIONS IN SYSTEMICSCLEROSIS: CLINICAL EVALUATION OF APERSONAL CASE SERIES OF 13 SCLERODERMAPATIENTS 187
Analysis of cryoproteins with a focus on cryofibrinogen: a study on 103 patients 187
The New Test for Monitoring Infliximab Therapy: From Laboratory to Clinical Practice 182
Patient characteristics of HCV-negative mixed cryoglobulinemia (MC) in Italy and Holland 180
Cryofibrinogen: A possibile risk factor in systemic sclerosis 176
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 176
Detection of autoimmunity in early primary Epstein-Barr virus infection by Western blot analysis 176
Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study 175
Ultrasonographic and clinical assessment of peripheral enthesitis and arthritis in an Italian cohort of inflammatory bowel disease patients 174
Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy 173
Does early arthritis clinic organisation improve outcomes? What evidence is there? A systematic review 172
Endothelial Dysfunction in Acute Hepatic Porphyrias 172
Cryoproteinemia: new frontiers for clinicians and the laboratory 170
Factors associated of long-term retention rate of Janus kinase inhibitors in a multi-failure rheumatoid arthritis population 164
Diagnosi di crioproteinemia: preziosa collaborazione tra laboratorio e clinica per la corretta gestione di una patologia rara 164
THE PREDICTIVE ROLE OF THE TAPSE/sPAP RATIO FOR CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS COMPLICATED BY PULMONARY HYPERTENSION 163
A CALL FOR A COMPREHENSIVE ROLE DEFINITION OF THE STUDY COORDINATOR IN RHEUMATOLOGICAL CLINICAL STUDIES 162
IS THERE A DISSOCIATION BETWEEN CLINICAL REMISSION AND ULTRASONOGRAPHIC ASSESSMENT IN RHEUMATOID ARTHRITIS? 159
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 157
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 157
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 148
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients 142
SAFETY AND EFFICACY OF INTRAVENOUS ILOPROST IN THE TREATMENT AND PREVENTION OF SCLERODERMA-RELATED DIGITAL ULCERS 141
PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability 140
The management of large vessel vasculitides 140
CONFRONTO TRA STRATEGIE DI TERAPIA AVANZATA DI 2° E 3° LINEA NELLA ARTRITE PSORIASICA: RISULTATI PRELIMINARI DALLO STUDIO OSSERVAZIONE RETROSPETTIVO BIRRA 138
Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability (Modern Pathology, (2020), 33, 7, (1398-1409), 10.1038/s41379-020-0497-0) 136
A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project 135
Role of COVID-19 in the progression of scleroderma interstitial lung disease and new onset pulmonary hypertension: a challenging case report. 130
Secondary cryofbrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study 128
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 126
CYCLING VS SWAP TNFi AND IL17i IN PSORIATIC ARTHRITIS: RESULTS FROM THE BIRRA RETROSPECTIVE OBSERVATIONAL STUDY 125
Cycling versus swapping strategieswith TNF-α inhibitors and IL-17 inhibitors in psoriatic arthritis in clinical practice 122
DIFFERENCES BETWEEN SELECTIVE AND UNSELECTIVE JAKi: RESULTS FROM A MULTICENTRIC, REAL LIFE STUDY CARRIED OUT ON PATIENTS WITH RA 120
Upadacitinib: One More Option in the Treatment of Patients with Rheumatoid Arthritis and Crohn's Disease 120
Secondary cryofibrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study. 118
POS0604 JAKi’S SURVIVAL RATE AND PREDICTORS OF DISCONTINUATION IN A COHORT OF PATIENTS WITH RHEUMATOID ARTHRITIS 117
Buerger's disease or thromboangiitis obliterans: description of two cases 117
Clinical and ultrasonographic predictors of disease activity after TNF-α inhibitor spacing in patients with psoriatic arthritis 111
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 111
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup— AMulticenter Study 105
The importance of body image and aesthetic medicine in systemic sclerosis 104
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis 101
Influence of safety warnings on the prescribing attitude of JAK 2inhibitors for rheumatoid arthritis in Italy 100
Totale 32.753
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.933
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021179 0 0 0 0 0 0 0 0 0 0 94 85
2021/20221.414 65 123 69 109 54 90 59 87 212 72 277 197
2022/20232.719 184 186 171 161 194 293 152 259 313 177 312 317
2023/20245.535 318 249 393 460 512 413 562 550 273 595 618 592
2024/20259.128 570 415 411 676 1.509 1.064 685 627 1.009 559 794 809
2025/20269.935 832 616 1.051 1.492 1.377 693 1.256 594 958 951 115 0
Totale 33.467